By buying an index fund, investors can approximate the average market return. But if you buy good businesses at...
“[Longevity] has been emerging in the mainstream for the past three to five years, and now it’s really reaching a critical mass of real applications that are coming into the clinic, into the market,” said Marco Quarta, chief executive officer of Rubedo Life Science.
Most readers would already be aware that Beiersdorf's (ETR:BEI) stock increased significantly by 9.8% over the past...